Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26108216 | 1.00 | MEN1 (0.36) | MEN1ALDH1A1GAAMAPTHPGD | |
| SCHEMBL26108660 | 0.95 | ADRB2 (0.32) | MEN1ALDH1A1GAAMAPTHPGD | |
| SCHEMBL30629061 | 0.95 | ADRB2 (0.32) | MEN1ALDH1A1GAAMAPTHPGD | |
| SCHEMBL30587810 | 0.86 | JAK2 (0.38) | MEN1ALDH1A1GAAMAPTHPGD | |
| SCHEMBL26109071 | 0.86 | JAK2 (0.38) | MEN1ALDH1A1GAAMAPTHPGD | |
| SCHEMBL26112264 | 0.83 | S1PR1 (0.35) | ALDH1A1GAAMAPT | |
| SCHEMBL30587801 | 0.83 | S1PR1 (0.35) | ALDH1A1GAAMAPT | |
| SCHEMBL30629082 | 0.81 | OPRM1 (0.34) | ALDH1A1GAAMAPT | |
| SCHEMBL26109227 | 0.80 | OPRM1 (0.34) | — | |
| SCHEMBL26109313 | 0.79 | S1PR1 (0.30) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116836157-A | Oxadiazole derivative and preparation method and application thereof | 星希尔生物科技(上海)有限公司 | 2023-10-03 | — | — | CN | disclosed |
| WO-2023179366-A1 | OXADIAZOLE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF | 星希尔生物科技(上海)有限公司 | 2023-09-28 | — | — | WO | disclosed |